Unknown

Dataset Information

0

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma.

ABSTRACT:

SUBMITTER: Morschhauser F 

PROVIDER: S-EPMC8257485 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL.
| S-EPMC4874222 | biostudies-literature
Unknown Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma.
| S-EPMC4260978 | biostudies-literature
Unknown A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma.
| S-EPMC6418474 | biostudies-literature
Unknown The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study.
| S-EPMC8330529 | biostudies-literature
Unknown An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma.
| S-EPMC6585960 | biostudies-literature
Unknown Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma.
| S-EPMC6356986 | biostudies-literature
Unknown Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial.
| S-EPMC6335739 | biostudies-literature
Unknown Phase 1 study of epacadostat in combination with atezolizumab for patients with previously treated advanced nonsmall cell lung cancer.
| S-EPMC7496129 | biostudies-literature
Unknown Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial.
| S-EPMC6198369 | biostudies-literature
Unknown Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma.
| S-EPMC4375715 | biostudies-literature